Simvastatin inhibits the development of radioresistant esophageal cancer cells by increasing the radiosensitivity and reversing EMT process via the PTEN-PI3K/AKT pathway

Authors:

Abstract
No abstract available

This publication has 30 references indexed in Scilit: